author-photo

Clare Y. Slaney

Peter MacCallum Cancer Centre
University of Melbourne

48

Papers

1682

Citations

Citation Trend

Filter By

Papers (48) Sort By

Journal Conference Others

Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Cellular networks controlling T cell persistence in adoptive cell therapy

2021 Nature Reviews Immunology
Show All
- Source
- Cite
- Save
Citations (5)
Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers

2021
Show All
- Source
- Cite
- Save
Citations (0)
A histone deacetylase inhibitor, panobinostat, enhances chimeric receptor antigen T cell anti-tumor effect against pancreatic cancer

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Cross-talk between tumors at anatomically distinct sites.

2020 FEBS Journal
Show All
- Source
- Cite
- Save
Citations (6)
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment.

2020 Clinical And Translational Immunology
Show All
- Source
- Cite
- Save
Citations (12)
Primary and metastatic breast tumors cross-talk to influence immunotherapy responses

2020 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (2)
Current status, challenges and perspectives: immunotherapy and tumour microenvironment in thoracic cancer

2020 Journal of Thoracic Disease
Show All
- Source
- Cite
- Save
Citations (0)
Chimeric antigen receptor T cell therapies for thoracic cancers— challenges and opportunities

2020 Journal of Thoracic Disease
Show All
- Source
- Cite
- Save
Citations (1)
Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells.

2020 Clinical And Translational Immunology
Show All
- Source
- Cite
- Save
Citations (8)